|
Staging is the process of finding out how far a cancer
hasspread. The stage of gallbladder cancer is one of the most important
factors in selecting treatment options and estimating a patient's
outlook for recovery and survival (prognosis).
A staging system is a standardized way for members of the
cancer care team to summarize the extent of a cancer's spread. The
stage of a cancer can be determined by the results of the physical
exam, imaging tests (ultrasound, CT or MRI scan, etc.) and other tests,
which are described in the section "How
is gallbladder cancer diagnosed?" and by the results of
surgery if it has been done.
The American Joint Committee on Cancer
(AJCC) TNM system
The major system used to describe the stages of gallbladder
cancer is the American Joint Committee on Cancer (AJCC) TNM system.
This system contains 3 key pieces of information:
- T
describes how far the primary tumor
has grown into the wall of the gallbladder and whether it has grown
into
other nearby organs or tissues.
- N
describes whether the cancer has metastasized (spread) to nearby
(regional) lymph nodes
(bean-sized
collections of immune system cells located throughout the body).
- M
indicates whether the cancer has metastasized
(spread) to other organs of the body. (The most common sites of
gallbladder cancer spread are the liver, peritoneum [the lining of the
abdominal cavity], and the lungs.)
Numbers or letters appear after T, N, and M to provide more
details about each of these factors:
- The numbers 0 through 4 indicate increasing severity.
- The letter X means "cannot be assessed" because the
information is not available.
Nearly all gallbladder cancers begin in the tissue on the
inside of the gallbladder. Over time they grow deeper into the
gallbladder, pushing through the various layers toward the outside of
the gallbladder.
The gallbladder wall has several layers. From the inside out,
these
are:
- the epithelium, a thin sheet of cells closest to the inside
of the gallbladder
- the lamina propria, a thin layer of loose connective tissue
(the epithelium plus the lamina propria form the mucosa)
- the muscularis, a layer of muscular tissue that helps the
gallbladder contract, squirting its bile into the bile duct
- the perimuscular ("around the muscle") fibrous tissue,
another layer of connective tissue
- the serosa, the outer covering of the gallbladder that
comes from the peritoneum, which is the lining of the abdominal cavity
The tumor may grow to fill some or all of the space inside the
gallbladder at the same time that it grows through the various layers
of gallbladder in the opposite direction. If it continues to grow, the
tumor may invade nearby organs, such as the liver, by growing directly
into those organs, or it may enter the lymphatic or blood vessels
within the gallbladder wall and spread to lymph nodes, the liver, and
other parts of the body.
T groups
TX: No
description of the tumor's extent is possible because of incomplete
information.
T0: No
evidence of primary tumor
Tis (carcinoma
in situ): Cancer cells are only found in the epithelium
(the
innermost layer of the gallbladder) and have not grown into (invaded)
deeper layers
of the gallbladder.
T1: The
tumor grows into the lamina propria or the muscle layer (muscularis).
- T1a:
Tumor grows into lamina propria.
- T1b: Tumor
grows into the muscle layer below the mucosa and lamina propria.
T2:
The tumor grows into perimuscular fibrous tissue.
T3: The
tumor has grown through the serosa (the outermost covering of the
gallbladder) and/or it has grown from the gallbladder directly into the
liver
and/or a nearby structure such as the stomach, duodenum
(first part of the small intestine), colon, pancreas, or bile ducts
outside the liver.
T4: The
tumor has grown into one of the main blood vessels leading into the
liver (portal
vein or hepatic artery) or it has grown into 2 or more organs outside
of
the liver.
Generally speaking, most doctors think T3 tumors are potentially
resectable (removable by surgery), while T4 tumors are not.
However, there may be other factors that affect whether surgery is a
good treatment option in any given case.
N groups
NX: Regional
(nearby) lymph nodes cannot be assessed.
N0: The
cancer has not spread to regional lymph nodes.
N1: The
cancer has spread to nearby lymph nodes.
M groups
MX: Distant
spread (metastasis) cannot be assessed.
M0: The
cancer has not spread to tissues or organs far away from the
gallbladder.
M1: The
cancer has spread to tissues or organs far away from the gallbladder.
TNM stage grouping
Once the T, N, and M categories have been determined, this
information is combined in a process called stage grouping. The
stage is expressed in Roman numerals from stage 0 (the least advanced)
to stage IV (the most advanced). Some stages are subdivided with
letters.
Stage 0: Tis,
N0, M0: There is a small cancer only in the epithelial
layer of the gallbladder. It has not spread outside of the gallbladder.
Stage IA: T1(a
or b), N0, M0: The tumor grows into the lamina propria
(T1a) or the
muscle layer (T1b). It has not spread outside of the gallbladder.
Stage IB: T2,
N0, M0: The tumor grows into the perimuscular fibrous
tissue. It has not spread outside of the gallbladder.
Stage IIA: T3,
N0, M0: The tumor extends through the serosa layer and/or
directly grows into the liver and/or one other nearby structure. It has
not spread to lymph nodes or to tissues or organs far away from the
gallbladder.
Stage IIB: T1 to
T3,
N1, M0: In addition to any growth in the gallbladder, the
tumor has spread to nearby lymph nodes (N1). It has not spread to
tissues or
organs far away from the gallbladder.
Stage III: T4,
any N, M0: Tumor invades the main blood vessels leading
into the liver or has reached more than one nearby organ other than the
liver. It may or may not have spread to lymph nodes. It has not spread
to tissues or organs far away from the gallbladder.
Stage IV: Any T,
any N, M1: The tumor has spread to tissues or organs far
away from the gallbladder.
Survival statistics by stage
Survival rates are a way for doctors to discuss and compare
the prognosis (outlook) for patients, based on the stage of the cancer
or other traits. The numbers below come from the American College of
Surgeons National Cancer Data Base and are based on more than 10,000
patients diagnosed with gallbladder cancer from 1989 to 1996. There are
some important points to note about these numbers:
- The 5-year
survival rate refers to the percentage of patients who
live at least 5 years
after being diagnosed. Of course, some of these patients live much
longer than 5 years after diagnosis.
- Although these numbers are among the most current we have
available, they represent people who were first diagnosed and treated
several years ago. Because of improvements in treatment since then,
survival rates for people now being diagnosed with these cancers may be
higher.
- Survival statistics can sometimes be useful as a general
guide, but they may not accurately represent any one person's
prognosis. A number of other factors, including other tumor
characteristics, how the cancer was treated, and a person's age and
general health, can also affect outlook. Your doctor is likely to be a
good source as to whether these numbers may apply to you, as he or she
is familiar with the aspects of your particular situation.
|
Stage
|
5-Year
Survival Rate |
| 0 |
81% |
| IA |
50% |
| IB |
29% |
| IIA |
7% |
| IIB |
9% |
| III |
3% |
| IV |
2% |
Grading gallbladder cancer
Another factor that can affect the patient's outlook
(prognosis) is the grade of the
cancer. The cancer's grade describes of how closely a cancer resembles
normal gallbladder tissue when looked at under a microscope.
The scale used for grading gallbladder cancers goes from G1
(where the cancer looks much like normal gallbladder tissue) to G4
(where the cancer looks very abnormal). The grades G2 and G3 fall
somewhere in between.
Typically, low-grade cancers are less likely to spread outside
the gallbladder than high-grade cancers, and have a more favorable
outlook. Intermediate grade cancers have an appearance and prognosis
between that of low- and high-grade cancers.
Last Medical Review: 11/02/2009 Last Revised: 11/02/2009
|